Solid Biosciences Inc Net debt/EBITDA
What is the Net debt/EBITDA of Solid Biosciences Inc?
The Net debt/EBITDA of Solid Biosciences Inc is 1.53
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on NASDAQ compared to Solid Biosciences Inc
What does Solid Biosciences Inc do?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Companies with net debt/ebitda similar to Solid Biosciences Inc
- Lennar has Net debt/EBITDA of 1.52
- Lennar has Net debt/EBITDA of 1.52
- Beyond Air has Net debt/EBITDA of 1.52
- First Defiance has Net debt/EBITDA of 1.53
- Resource Mining has Net debt/EBITDA of 1.53
- Baumart has Net debt/EBITDA of 1.53
- Solid Biosciences Inc has Net debt/EBITDA of 1.53
- Fuels has Net debt/EBITDA of 1.53
- Haidilao International has Net debt/EBITDA of 1.53
- WesCan has Net debt/EBITDA of 1.53
- HongGuang Lighting has Net debt/EBITDA of 1.54
- Sonoma Pharmaceuticals has Net debt/EBITDA of 1.54
- Surge Copper has Net debt/EBITDA of 1.54